Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Not Confirmed
Not Confirmed
26-28 May, 2026
Not Confirmed
Not Confirmed
27-28 May, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Industry Trade Show
Not Confirmed
26-28 May, 2026
Industry Trade Show
Not Confirmed
27-28 May, 2026
Digital content

12 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/12/3292887/0/en/connect-biopharma-reports-first-quarter-2026-financial-results-and-provides-business-update.html

12 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/12/3293365/0/en/connect-biopharma-to-present-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference.html

23 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/23/3280016/0/en/connect-biopharma-announces-enrollment-in-phase-2-seabreeze-stat-studies-will-continue-as-planned-following-pre-specified-interim-analysis.html

31 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/31/3266034/0/en/Connect-Biopharma-Reports-2025-Full-Year-Financial-Results-and-Provides-Business-Update.html

31 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/30/3264498/0/en/Rademikibart-Demonstrates-Best-in-Class-Potential-in-Phase-3-Atopic-Dermatitis-Study.html

30 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/30/3264480/0/en/Connect-Biopharma-Announces-Positive-Topline-Data-from-its-Phase-1-Study-of-Intravenous-IV-Rademikibart-in-Patients-with-Asthma-or-COPD.html
ABOUT THIS PAGE